Members in the News

June 15th, 2023

In a new multicenter study, researchers from Georgetown University’s Lombardi Comprehensive Cancer Center, the Medical College of Wisconsin (MCW), UCLA and several other leading cancer centers from across the nation examined whether cancer and its treatments accelerate aging. Using novel epigenetic measures to assess biological aging, investigators found that older breast cancer survivors — particularly those exposed to chemotherapy — showed greater epigenetic aging than their same-aged peers without cancer, which may relate to worse outcomes.…

September 30th, 2022

Scientists are still trying to understand why many breast cancer survivors experience troubling cognitive problems for years after treatment. Inflammation is one possible culprit. A new long-term study of older breast cancer survivors, published today in the Journal of Clinical Oncology, adds important evidence to that potential link. …

July 6th, 2022

Dear Members of the Lombardi Community, I am delighted to announce the appointment of Jeanne Mandelblatt, MD, MPH as the Frank M. Ewing Foundation Endowed Chair. Established in 2018, the Ewing…

May 2nd, 2022

Results from the Thinking and Living with Cancer Study (TLC) showed that the development of sleep disturbances during the early months of the COVID-19 pandemic increased symptoms of depression and anxiety among older women, but the findings did not differ between women who survived breast cancer and women without cancer. It is the first study to assess sleep disturbances and mental health outcomes among cancer survivors during the pandemic.…

April 24th, 2022

News4’s Pat Lawson Muse talks with Dr. Jeanne Mandelblatt of Georgetown Lombardi Institute for Cancer & Aging.…

December 6th, 2021

A McCourt researcher has dedicated her career to aging research and a decades-old study, revealing a non-medical intervention that proves resilient against dementia.…

November 12th, 2021

In an unexpected discovery, Georgetown University Medical Center researchers have identified what appears to be a significant vascular defect in patients with moderately severe Parkinson’s disease. The finding could help explain an earlier outcome of the same study, in which the drug nilotinib was able to halt motor and nonmotor (cognition and quality of life) decline in the long term.…

March 28th, 2021

When Jeanne Mandelblatt, MD, PhD, MPH, reflects on the arc of her research career, she sees no single standout moment that cemented her path. Instead, the revered member of Georgetown Lombardi Comprehensive Cancer Center and professor of oncology and medicine at Georgetown attributes her distinguished career to a continuum of work “based on persistence, curiosity and serendipity,” coupled with work involving wonderful transdisciplinary teams of colleagues.…